Lv1
38 积分 2023-10-26 加入
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
2个月前
已完结
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
2个月前
已完结
内镜黏膜下剥离术在原发性胃肠道淋巴瘤诊断中的价值
3个月前
已完结
Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement
5个月前
已完结
IFN-γ promotes the progression of iMCD by activating inflammatory monocytes
8个月前
已完结
Amino Acid Difference Formula to Help Explain Protein Evolution
9个月前
已完结
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
9个月前
已完结
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
9个月前
已完结
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation
11个月前
已关闭
皖公网安备34019202002308
